J.G.Chemicals share price today

J.G.Chemicals Ltd's share price was ₹575.75 at the close on 5 November 2026. It has been rising for 23 weeks. That is 14.9% above its average price over the last 200 trading days. In the last 52 weeks it traded between ₹309 and ₹651, and at that close it sat 78% of the way up from that low.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today J.G.Chemicals Ltd is in stage 2. The phase helps read everything below.

Over the past 13 weeks it has done better than the NIFTY 500, and it has stayed ahead for 19 weeks in a row.

Over the last 2.6 years the share price moved +196% while the NIFTY 500 moved +12%, so it is ahead of the index over that whole period. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

Three changes stood out: revenue up on a year earlier for 9 quarters in a row, indian funds and insurers (DIIs) cut their stake for 3 quarters in a row and highest quarterly profit in 14 quarters.

1. Revenue up on a year earlier for 9 quarters in a row

   In the June 2026 quarter revenue was ₹316 crore, +45% on a year earlier.

   Why: Revenue rose because demand was strong across tyres, rubber, ceramics, pharma and specialty chemicals, and the company sold more in every category.

   Next results: check whether that demand carries into this quarter, as management said it was continuing.

   From the earnings call on 10 Aug 2026.

2. Indian funds and insurers (DIIs) cut their stake for 3 quarters in a row

   From 3.5% to 2.1% of the company by the September 2026 quarter.

3. Highest quarterly profit in 14 quarters

   Profit of ₹26 crore in the June 2026 quarter is the highest of the last 14 quarters.

   Why: Profit was the highest because the company ran its plants fuller, sold more higher-priced special orders, cut costs and sold more non-tyre products. Inventory timing also helped a little.

   Next results: check whether higher-value orders and cost cuts keep the profit margin up as the inventory timing help fades.

   From the earnings call on 10 Aug 2026.

For July to September 2026 (the quarter ended 30 September 2026), J.G.Chemicals reported revenue of ₹361 crore, up 64.1% from ₹220 crore a year earlier, and a profit of ₹28.0 crore, up 86.7% from ₹15.0 crore.

J.G.Chemicals results: July to September 2026 against a year earlier

The next results, for October to December 2026, are due by 14 February 2027: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter).

The newest call in our records is from 10 August 2026, about April to June 2026; a call about these results is not in our records yet.

From the company's reported quarterly results (quarter ended 30 September 2026). Revenue and profit in ₹ crore.

J.G.Chemicals closed at ₹575.75 on 5 November 2026, up 37.9% from ₹417.45 a year earlier (7 November 2025). Its highest weekly close since March 2024 was ₹651.30 on 28 August 2026.

J.G.Chemicals share price: then and now

Weekly closing prices. Each change is the move from that price to the 5 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes.

143 weekly closes from 15 March 2024 to 5 November 2026.

5 Nov 2026: J.G.Chemicals closed at ₹575.75, up 2.4% on the week and down 8.7% on the month. Results for July to September 2026: Revenue up 64.1% and profit up 86.7% on a year earlier.

Earlier

• 23 Sep 2026: ex-date for a dividend of ₹1.10 a share.
• 10 Aug 2026: J.G.Chemicals held its results call for April to June 2026. Management guided: Dahej Phase 1 and Naidupeta brownfield commissioning in October to December 2026; Dahej timing narrowed to November.

J.G.Chemicals paid ₹1.10 a share in regular dividends in the 12 months to 5 November 2026 (1 payment), a yield of 0.19% at the ₹575.75 close on 5 November 2026. The last was a dividend of ₹1.10 a share, ex-date 23 September 2026.

J.G.Chemicals dividends since 1 April 2021

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. The record date is the same day as the ex-date for every payment here.

Not in its latest year. J.G.Chemicals Ltd paid out 0% of its profit as dividends in FY26. It did pay a dividend in 1 of its last 7 reported years, so there is a history but no current dividend.

From the NSE corporate-actions record, read 5 November 2026.

On the call for April to June 2026, held on 10 August 2026, J.G.Chemicals' management guided: Dahej Phase 1 and Naidupeta brownfield commissioning in October to December 2026; Dahej timing narrowed to November.

“So, we are neutral to zinc prices if you ask me honestly. So whether zinc is at 3,000 or 3,500 or 3,600 it really doesn't matter to us.”Anuj Jhunjhunwala, CFO, on the call for April to June 2026

What management guided

• Dahej Phase 1 capacity 15,000-17,000 MTPA, revenue potential ₹300-400 crore and operating margin 11-12%.
• Dahej addition above 40,000 MTPA and combined zinc-chemicals capacity above 115,000 MTPA after both phases; about ₹100 crore of spending and ₹900 crore revenue potential.
• Dahej utilization 50-60% in FY28 and 70-80% in FY29; Phase 2 construction to begin as utilization rises.
• Current-year operating margin expected to remain in the stated 10-12% range; subsequent consolidated goal approximately 14-15%.

Management’s own plans and goals, from our notes of the call. A plan is not a result.

Source: the call transcript.

From the call for April to June 2026, 10 August 2026. The July to September 2026 results are out since, so this part may be out of date until we update it.

When J.G.Chemicals reports October to December 2026, these are the 4 checks that show whether the story is still on course. First: Dahej and Naidupeta commissioning against the indicated window; check equipment installation, approvals and customer readiness.

J.G.Chemicals is on one of our India lists: Momentum stocks.

J.G.Chemicals Ltd earned ₹28.0 Cr of net profit in the Sep 2026 quarter, +86.7% on the same quarter a year earlier. That is the 3rd quarter in a row of profit growth. Full-year FY26 profit was ₹69.0 Cr. Over 6 years profit has grown 30.5% a year on average. That is 7.8% of the quarter's revenue.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

The same quarter a year earlier earned ₹15.0 Cr.

For the full year, FY26 profit was ₹69.0 Cr (+3.0% on the year before).

Why profit moved: revenue changed +64.1% on a year earlier and the margin moved +3.0 percentage points. Most of the change came from keeping more of each sale.

On average over the last four quarters, profit changed +42.0% and revenue +38.9%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra rupee of revenue adds more to profit.

J.G.Chemicals Ltd reported ₹361 Cr of revenue in the Sep 2026 quarter, +64.1% on the same quarter a year earlier. That is the 10th quarter in a row with growth on the year before. Over 6 years it has grown 16.0% a year on average. The last full year, FY26, came in at ₹972 Cr.

Revenue is everything the company billed its customers in the period.

The last four reported quarters add to ₹1,211 Cr.

FY26 revenue was ₹972 Cr, +14.8% on the year before.

Recent pace: the last four quarters grew +38.9% on average, against 16.0% a year over the longer run, so this year is growing faster than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +39.0%, against +26.5% a year over the last 8 quarters (accelerating); profit over the last 12 months grew +40.0%, against +25.3% a year (accelerating).

J.G.Chemicals Ltd's operating margin was 11.0% in the Sep 2026 quarter, 3.0 percentage points higher than the same quarter a year ago. Across 7 years it has been between 4.9% and 10.0%. The latest quarter is above every full year in that period.

Operating margin is what is left from every ₹100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why the margin moved: operating margin changed +2.4 percentage points on the year while gross margin changed −0.1 points. So the gain came mostly from costs below the gross margin, such as staff and overheads, measured against sales.

Over the last 3 years, 65% of J.G.Chemicals Ltd's reported profit came in as cash from its operations, so most of the profit is real cash. In FY26 it brought in ₹44.0 Cr of operating cash against ₹69.0 Cr of profit. After ₹40.0 Cr of spending on assets, ₹4.0 Cr was left over as free cash.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

Why 65% of profit came in as cash: the cash cycle got 18 days shorter between FY21 and FY26, so cash that used to wait in the business now arrives sooner. When less than 70% of profit comes in as cash, it is the thing to watch on this page.

What to look at next: the bigger use of cash is spending on new assets, at 3.6× depreciation over three years. The next section checks what that spending is building.

J.G.Chemicals Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 101 days in FY26, down from 119 days in FY21. It spent ₹54.0 Cr on assets over the last 3 years. Customers take 64 days to pay, and stock sits for 42 days on average.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

At FY26 sales of ₹972 Cr, each day of that cycle ties up about ₹2.7 Cr, so roughly ₹269 Cr is tied up in the business at any time.

FY26: customers took 64 days to pay and stock sat for 42 days, about 1.4 months of sales sitting as stock, for a full cycle of 101 days, shorter than FY21's 119.

The full loop: cash goes out to suppliers and production on day 0. Stock sits for 42 days. Customers pay about 64 days after that. Suppliers are paid at 5 days. Together that makes the 101-day cycle.

Spending on assets: ₹54.0 Cr over the last 3 years, against ₹15.0 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹8.0 Cr (FY26): assets paid for that are not earning yet.

In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns.

J.G.Chemicals Ltd's P/E is 25.8×, in the middle of its own history: higher than 59% of past readings. Its usual P/E (the middle reading) is 25.0×, over 2.6 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many rupees the market pays for each rupee of yearly profit.

Why the multiple is where it is: over the past year earnings per share moved +2.8% while the price moved +37.9%. The price did better than earnings, which pushed the multiple up within its own range.

In short: the multiple is about average against its own past, so the earnings trend underneath matters more than the multiple.

A quarterly PEG curve, which only the second data source has, is not shown on this page: its two data sources disagree by up to 11% on reported income across 14 comparable periods. When two sources disagree on a figure, we leave it out on purpose. The gap is a choice, not missing data.

J.G.Chemicals Ltd's business is growing steadily. Revenue, profit and EPS growth have stayed positive throughout, and ROCE is steady at 18.0%. This is based on 8 quarters of 4 measures, with some gaps.

Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.

Why it matters: steady growth with healthy returns is how a business compounds over time.

The return figures here are yearly, not quarterly. They show level and direction only; they can support the growth lines but never decide the reading alone.

This reading has some gaps: at least one line is short, or the return line is not the quarterly series, so treat it with a little more caution.

Compound annual growth rate (%)

Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the share price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.

J.G.Chemicals Ltd earned a ROCE of 18% in FY26. That is up from a low of 14% in FY24. We cannot compare its return on capital used with its cost of capital from the data we have. It comes from a 7.1% net margin and 1.71× asset turnover (sales divided by assets).

Return on capital employed (ROCE) is the profit the whole business earns on all the money in it, from shareholders and lenders together. It is the best single test of whether growth adds value or just size.

Why the return is what it is (FY26): a 7.1% net margin × 1.71× asset turnover × 1.08× leverage (assets divided by equity) ≈ 13.1% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed.

The quarterly return lines and the return-on-capital-used (ROIC) line, which only the second data source has, are not shown on this page: its two data sources disagree by up to 11% on reported income across 14 comparable periods. When two sources disagree on a figure, we leave it out on purpose. The gap is a choice, not missing data.

J.G.Chemicals Ltd had ₹6.0 Cr of borrowings against ₹528 Cr of equity in FY26, so its debt is 0.01× its equity. Its operating profit is 82 times its interest bill. Over 5 years borrowings went from ₹74.0 Cr to ₹6.0 Cr. Over the last 3 of those years it spent ₹54.0 Cr on assets.

Debt-to-equity shows how much of the business is paid for with borrowed money. Interest cover shows how many times operating profit pays the interest bill. Low debt and high cover are the safe combination.

The spending on assets is being paid for from cash, not new debt.

The total-debt and debt-to-equity series, which only the second data source has, are not shown on this page: its two data sources disagree by up to 11% on reported income across 14 comparable periods. When two sources disagree on a figure, we leave it out on purpose. The gap is a choice, not missing data.

Foreign institutions cut their stake in J.G.Chemicals Ltd by 2.8 percentage points over 8 quarters, the biggest change among its owners. Foreign institutions now own 3.8% of the company. Domestic institutions moved −1.6 points over the same period, to 2.1%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings.

Who owns the company each quarter: promoters (the founders or controlling owners), foreign institutions, domestic institutions such as mutual funds, and the public. When people close to the business steadily raise their stake, that is worth noticing; a quiet list is also an answer.

Over the last two years: Foreign institutions: −2.8 points over 8 quarters, to 3.8%; Domestic institutions: −1.6 points over 8 quarters, to 2.1%; Promoters: +0.0 points over 8 quarters, to 71.0%.

Why the owners changed: foreign institutions drove it (−2.8 points), together with domestic institutions (−1.6 points). They reduced their stake.

For J.G.Chemicals Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date.

The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.

58.3 out of 100, rank 3 of 9 in Chemicals - Inorganic, with 67% of the evidence available.

J.G.Chemicals Ltd scores 58.3 out of 100 against the 9 companies it is compared with in Chemicals - Inorganic, ranking 3. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.

The four parts add up to the total exactly: 23 + 15.5 + 7.8 + 12 = 58.3. This is the same number shown on the industry page; it is worked out once for the whole group and read here.

What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector.

J.G.Chemicals ranks 3 of 9 Chemicals - Inorganic companies on the 4-Factor Sector Score, with 58.3 out of 100.

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read.

The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section.

Related companies: Chemicals - Inorganic, all 9 compared on one page.

J.G.Chemicals is the 4th largest of 9 Chemicals - Inorganic companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Deepak Nitrite, Tanfac Industries and Archean Chemical Industries. Just below it: Fischer Medical Ventures, Indo Borax & Chemicals and Sree Rayalaseema Hi-Strength Hypo.

Chemicals - Inorganic companies close in size

1. Deepak Nitrite Ltd ₹20,724 crore
2. Tanfac Industries Ltd ₹7,266 crore
3. Archean Chemical Industries Ltd ₹5,460 crore
4. J.G.Chemicals Ltd ₹2,258 crore
5. Fischer Medical Ventures Ltd ₹1,732 crore
6. Indo Borax & Chemicals Ltd ₹1,394 crore
7. Sree Rayalaseema Hi-Strength Hypo Ltd ₹833 crore

All 9 Chemicals - Inorganic companies, largest first

Companies close in size in other industries

1182. Shanti Gold International Ltd ₹2,266 crore · Diamond, Gems & Jewellery
1183. Sakar Healthcare Ltd ₹2,260 crore · Hospitals
1184. J.G.Chemicals Ltd ₹2,258 crore
1185. Sundaram Clayton Ltd ₹2,258 crore · Castings, Forgings & Fastners
1186. Eveready Industries India Ltd ₹2,257 crore · Miscellaneous

Sector Alpha, written by code from the published numbers. Data as of 5 November 2026.

Every chart on this page is drawn by code from the published figures, with no forecasts and no price opinions.

See the plain-text version of this page.